Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Westlake Chemical Partners (WLKP) Asset Writedowns and Impairment (2016 - 2017)

Historic Asset Writedowns and Impairment for Westlake Chemical Partners (WLKP) over the last 5 years, with Q3 2017 value amounting to -$500000.0.

  • Westlake Chemical Partners' Asset Writedowns and Impairment fell 36178.01% to -$500000.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $141000.0, marking a year-over-year decrease of 3815.79%. This contributed to the annual value of $394000.0 for FY2016, which is 13176.47% up from last year.
  • Westlake Chemical Partners' Asset Writedowns and Impairment amounted to -$500000.0 in Q3 2017, which was down 36178.01% from -$500000.0 recorded in Q2 2017.
  • In the past 5 years, Westlake Chemical Partners' Asset Writedowns and Impairment ranged from a high of $975000.0 in Q1 2017 and a low of -$500000.0 during Q2 2017
  • In the last 5 years, Westlake Chemical Partners' Asset Writedowns and Impairment had a median value of $115500.0 in 2013 and averaged $71000.0.
  • Per our database at Business Quant, Westlake Chemical Partners' Asset Writedowns and Impairment soared by 3600.0% in 2015 and then crashed by 145135.14% in 2017.
  • Quarter analysis of 5 years shows Westlake Chemical Partners' Asset Writedowns and Impairment stood at $106000.0 in 2013, then rose by 17.92% to $125000.0 in 2014, then surged by 36.0% to $170000.0 in 2015, then fell by 2.35% to $166000.0 in 2016, then tumbled by 401.2% to -$500000.0 in 2017.
  • Its last three reported values are -$500000.0 in Q3 2017, -$500000.0 for Q2 2017, and $975000.0 during Q1 2017.